APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exoskeleton

An Exoskeleton is a wearable robot that combines human intelligence and machine power. It is widely used for rehabilitation applications such as tendon therapy and physical exercise, and supports finger flexion and extension movements.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An Exoskeleton is a wearable robot that combines human intelligence and machine power. It is widely used for rehabilitation applications such as tendon therapy and physical exercise, and supports finger flexion and extension movements.

Selected research

Market Outlook & Growth Opportunities

Global Exoskeleton Market Outlook and Growth Opportunities 2026

26 December 2025194 pages

Choose your research edition.

Industry ResearchExoskeleton Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Exoskeleton Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Exoskeleton Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exoskeleton Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Exoskeleton Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

An Exoskeleton is a wearable robot that combines human intelligence and machine power. It is widely used for rehabilitation applications such as tendon therapy and physical exercise, and supports finger flexion and extension movements.

United States is the largest Exoskeleton market with about 81% market share. Asia-Pacific is follower, accounting for about 28% market share.

The key players are Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics, LockHeed Martin, Parker Hannifin, Interactive Motion Technologies, Panasonic, Myomo, B-TEMIA Inc., Alter G, US Bionics etc. Top 3 companies occupied about 76% market share.

Read the full market overview

This report provides an overview of the global Exoskeleton market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exoskeleton and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exoskeleton sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exoskeleton market size, projected growth trends, production technologies, key applications, and end-use industries.

Exoskeleton Segment by Company

Cyberdyne

Hocoma

ReWalk Robotics

Ekso Bionics

LockHeed Martin

Parker Hannifin

Interactive Motion Technologies

Panasonic

Myomo

B-TEMIA Inc.

Alter G

US Bionics

Exoskeleton Segment by Type

Lower

Upper

Full Body

Exoskeleton Segment by Application

Healthcare

Defense

Industrial

Exoskeleton Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exoskeleton status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Exoskeleton market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exoskeleton significant trends, drivers, influence factors in global and regions.

6. To analyze Exoskeleton competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exoskeleton market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exoskeleton industry.

Chapter 3: Detailed analysis of Exoskeleton manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Exoskeleton in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Exoskeleton in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exoskeleton Industry Trends Table 2. Exoskeleton Industry Drivers Table 3. Exoskeleton Industry Opportunities and Challenges Table 4. Exoskeleton Industry Restraints Table 5. Global Exoskeleton Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exoskeleton Revenue Share by Company (2021-2026) Table 7. Global Exoskeleton Sales Volume by Company (Units) & (2021-2026) Table 8. Global Exoskeleton Sales Volume Share by Company (2021-2026) Table 9. Global Exoskeleton Average Price (K USD/Unit) of Company (2021-2026) Table 10. Global Exoskeleton Company Ranking, (2024-2026) & (USD Million) Table 11. Global Exoskeleton Key Company Manufacturing Base & Headquarters Table 12. Global Exoskeleton Company, Product Type & Application Table 13. Global Exoskeleton Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Exoskeleton by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lower Table 18. Significant Companies of Upper Table 19. Significant Companies of Full Body Table 20. Global Exoskeleton Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Exoskeleton Sales Volume by Type (2021-2026) & (Units) Table 22. Global Exoskeleton Sales Volume by Type (2027-2032) & (Units) Table 23. Global Exoskeleton Sales Volume Share by Type (2021-2026) Table 24. Global Exoskeleton Sales Volume Share by Type (2027-2032) Table 25. Global Exoskeleton Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Exoskeleton Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Exoskeleton Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Exoskeleton Sales Value Share by Type (2021-2026) Table 29. Global Exoskeleton Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Healthcare Table 31. Significant Companies of Defense Table 32. Significant Companies of Industrial Table 33. Global Exoskeleton Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Exoskeleton Sales Volume by Application (2021-2026) & (Units) Table 35. Global Exoskeleton Sales Volume by Application (2027-2032) & (Units) Table 36. Global Exoskeleton Sales Volume Share by Application (2021-2026) Table 37. Global Exoskeleton Sales Volume Share by Application (2027-2032) Table 38. Global Exoskeleton Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Exoskeleton Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Exoskeleton Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Exoskeleton Sales Value Share by Application (2021-2026) Table 42. Global Exoskeleton Sales Value Share by Application (2027-2032) Table 43. Global Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Exoskeleton Sales by Region (2021-2026) & (Units) Table 45. Global Exoskeleton Sales Market Share by Region (2021-2026) Table 46. Global Exoskeleton Sales by Region (2027-2032) & (Units) Table 47. Global Exoskeleton Sales Market Share by Region (2027-2032) Table 48. Global Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Exoskeleton Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Exoskeleton Sales Value Share by Region (2021-2026) Table 51. Global Exoskeleton Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Exoskeleton Sales Value Share by Region (2027-2032) Table 53. Global Exoskeleton Market Average Price (K USD/Unit) by Region (2021-2026) Table 54. Global Exoskeleton Market Average Price (K USD/Unit) by Region (2027-2032) Table 55. Global Exoskeleton Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Exoskeleton Sales by Country (2021-2026) & (Units) Table 58. Global Exoskeleton Sales Market Share by Country (2021-2026) Table 59. Global Exoskeleton Sales by Country (2027-2032) & (Units) Table 60. Global Exoskeleton Sales Market Share by Country (2027-2032) Table 61. Global Exoskeleton Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Exoskeleton Sales Value Market Share by Country (2021-2026) Table 63. Global Exoskeleton Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Exoskeleton Sales Value Market Share by Country (2027-2032) Table 65. Cyberdyne Company Information Table 66. Cyberdyne Business Overview Table 67. Cyberdyne Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 68. Cyberdyne Exoskeleton Product Portfolio Table 69. Cyberdyne Recent Development Table 70. Hocoma Company Information Table 71. Hocoma Business Overview Table 72. Hocoma Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 73. Hocoma Exoskeleton Product Portfolio Table 74. Hocoma Recent Development Table 75. ReWalk Robotics Company Information Table 76. ReWalk Robotics Business Overview Table 77. ReWalk Robotics Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 78. ReWalk Robotics Exoskeleton Product Portfolio Table 79. ReWalk Robotics Recent Development Table 80. Ekso Bionics Company Information Table 81. Ekso Bionics Business Overview Table 82. Ekso Bionics Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 83. Ekso Bionics Exoskeleton Product Portfolio Table 84. Ekso Bionics Recent Development Table 85. LockHeed Martin Company Information Table 86. LockHeed Martin Business Overview Table 87. LockHeed Martin Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 88. LockHeed Martin Exoskeleton Product Portfolio Table 89. LockHeed Martin Recent Development Table 90. Parker Hannifin Company Information Table 91. Parker Hannifin Business Overview Table 92. Parker Hannifin Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 93. Parker Hannifin Exoskeleton Product Portfolio Table 94. Parker Hannifin Recent Development Table 95. Interactive Motion Technologies Company Information Table 96. Interactive Motion Technologies Business Overview Table 97. Interactive Motion Technologies Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 98. Interactive Motion Technologies Exoskeleton Product Portfolio Table 99. Interactive Motion Technologies Recent Development Table 100. Panasonic Company Information Table 101. Panasonic Business Overview Table 102. Panasonic Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 103. Panasonic Exoskeleton Product Portfolio Table 104. Panasonic Recent Development Table 105. Myomo Company Information Table 106. Myomo Business Overview Table 107. Myomo Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 108. Myomo Exoskeleton Product Portfolio Table 109. Myomo Recent Development Table 110. B-TEMIA Inc. Company Information Table 111. B-TEMIA Inc. Business Overview Table 112. B-TEMIA Inc. Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 113. B-TEMIA Inc. Exoskeleton Product Portfolio Table 114. B-TEMIA Inc. Recent Development Table 115. Alter G Company Information Table 116. Alter G Business Overview Table 117. Alter G Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 118. Alter G Exoskeleton Product Portfolio Table 119. Alter G Recent Development Table 120. US Bionics Company Information Table 121. US Bionics Business Overview Table 122. US Bionics Exoskeleton Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 123. US Bionics Exoskeleton Product Portfolio Table 124. US Bionics Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Exoskeleton Distributors List Table 128. Exoskeleton Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Exoskeleton Product Image Figure 2. Global Exoskeleton Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 4. Global Exoskeleton Sales (2021-2032) & (Units) Figure 5. Global Exoskeleton Sales Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Exoskeleton Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lower Image Figure 10. Upper Image Figure 11. Full Body Image Figure 12. Global Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Exoskeleton Sales Volume Share by Type (2021-2032) Figure 15. Global Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Exoskeleton Sales Value Share by Type (2021-2032) Figure 18. Healthcare Image Figure 19. Defense Image Figure 20. Industrial Image Figure 21. Global Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Exoskeleton Sales Volume Share by Application (2021-2032) Figure 24. Global Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Exoskeleton Sales Value Share by Application (2021-2032) Figure 27. Global Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Exoskeleton Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Exoskeleton Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 32. North America Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 38. South America Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Exoskeleton Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Exoskeleton Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Lower
  • Upper
  • Full Body
Applications
  • Healthcare
  • Defense
  • Industrial
Companies covered
  • Cyberdyne
  • Hocoma
  • ReWalk Robotics
  • Ekso Bionics
  • LockHeed Martin
  • Parker Hannifin
  • Interactive Motion Technologies
  • Panasonic
  • Myomo
  • B-TEMIA Inc.
  • Alter G
  • US Bionics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoskeleton Sales Value (2021-2032)
  4. 1.2.2 Global Exoskeleton Sales Volume (2021-2032)
  5. 1.2.3 Global Exoskeleton Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Exoskeleton Market Dynamics
  1. 2.1 Exoskeleton Industry Trends
  2. 2.2 Exoskeleton Industry Drivers
  3. 2.3 Exoskeleton Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Industry Restraints
3 Exoskeleton Market by Company
  1. 3.1 Global Exoskeleton Company Revenue Ranking in 2025
  2. 3.2 Global Exoskeleton Revenue by Company (2021-2026)
  3. 3.3 Global Exoskeleton Sales Volume by Company (2021-2026)
  4. 3.4 Global Exoskeleton Average Price by Company (2021-2026)
  5. 3.5 Global Exoskeleton Company Ranking (2024-2026)
  6. 3.6 Global Exoskeleton Company Manufacturing Base and Headquarters
  7. 3.7 Global Exoskeleton Company Product Type and Application
  8. 3.8 Global Exoskeleton Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Exoskeleton Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Exoskeleton Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Exoskeleton Market by Type
  1. 4.1 Exoskeleton Type Introduction
  2. 4.1.1 Lower
  3. 4.1.2 Upper
  4. 4.1.3 Full Body
  5. 4.2 Global Exoskeleton Sales Volume by Type
  6. 4.2.1 Global Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exoskeleton Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Exoskeleton Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Exoskeleton Sales Value by Type
  10. 4.3.1 Global Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Exoskeleton Sales Value by Type (2021-2032)
  12. 4.3.3 Global Exoskeleton Sales Value Share by Type (2021-2032)
5 Exoskeleton Market by Application
  1. 5.1 Exoskeleton Application Introduction
  2. 5.1.1 Healthcare
  3. 5.1.2 Defense
  4. 5.1.3 Industrial
  5. 5.2 Global Exoskeleton Sales Volume by Application
  6. 5.2.1 Global Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exoskeleton Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Exoskeleton Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Exoskeleton Sales Value by Application
  10. 5.3.1 Global Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Exoskeleton Sales Value by Application (2021-2032)
  12. 5.3.3 Global Exoskeleton Sales Value Share by Application (2021-2032)
6 Exoskeleton Regional Sales and Value Analysis
  1. 6.1 Global Exoskeleton Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exoskeleton Sales by Region (2021-2032)
  3. 6.2.1 Global Exoskeleton Sales by Region: 2021-2026
  4. 6.2.2 Global Exoskeleton Sales by Region (2027-2032)
  5. 6.3 Global Exoskeleton Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Exoskeleton Sales Value by Region (2021-2032)
  7. 6.4.1 Global Exoskeleton Sales Value by Region: 2021-2026
  8. 6.4.2 Global Exoskeleton Sales Value by Region (2027-2032)
  9. 6.5 Global Exoskeleton Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Exoskeleton Sales Value (2021-2032)
  12. 6.6.2 North America Exoskeleton Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Exoskeleton Sales Value (2021-2032)
  15. 6.7.2 Europe Exoskeleton Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Exoskeleton Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Exoskeleton Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Exoskeleton Sales Value (2021-2032)
  21. 6.9.2 South America Exoskeleton Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Exoskeleton Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Exoskeleton Sales Value Share by Country, 2025 VS 2032
7 Exoskeleton Country-level Sales and Value Analysis
  1. 7.1 Global Exoskeleton Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Exoskeleton Sales by Country (2021-2032)
  4. 7.3.1 Global Exoskeleton Sales by Country (2021-2026)
  5. 7.3.2 Global Exoskeleton Sales by Country (2027-2032)
  6. 7.4 Global Exoskeleton Sales Value by Country (2021-2032)
  7. 7.4.1 Global Exoskeleton Sales Value by Country (2021-2026)
  8. 7.4.2 Global Exoskeleton Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Exoskeleton Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Exoskeleton Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Exoskeleton Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Exoskeleton Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Exoskeleton Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Exoskeleton Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Exoskeleton Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Exoskeleton Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Exoskeleton Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Exoskeleton Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Exoskeleton Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Exoskeleton Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Exoskeleton Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Exoskeleton Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Exoskeleton Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Exoskeleton Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Exoskeleton Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Exoskeleton Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Exoskeleton Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Exoskeleton Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Exoskeleton Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Exoskeleton Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Exoskeleton Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Exoskeleton Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Exoskeleton Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Exoskeleton Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Exoskeleton Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Exoskeleton Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Exoskeleton Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Exoskeleton Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Exoskeleton Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Exoskeleton Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Exoskeleton Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Exoskeleton Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Exoskeleton Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Exoskeleton Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Exoskeleton Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Exoskeleton Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Exoskeleton Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Exoskeleton Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Exoskeleton Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Exoskeleton Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Exoskeleton Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Exoskeleton Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Exoskeleton Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Exoskeleton Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Exoskeleton Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Exoskeleton Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Exoskeleton Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Exoskeleton Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Exoskeleton Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Exoskeleton Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Exoskeleton Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Exoskeleton Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Exoskeleton Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Exoskeleton Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Exoskeleton Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Exoskeleton Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Exoskeleton Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Exoskeleton Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Exoskeleton Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Exoskeleton Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Exoskeleton Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Exoskeleton Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Exoskeleton Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Exoskeleton Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Exoskeleton Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Exoskeleton Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Exoskeleton Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Exoskeleton Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Exoskeleton Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Exoskeleton Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Exoskeleton Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Exoskeleton Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Exoskeleton Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Exoskeleton Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Exoskeleton Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Exoskeleton Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Exoskeleton Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Exoskeleton Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Exoskeleton Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Exoskeleton Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Exoskeleton Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Exoskeleton Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cyberdyne
  2. 8.1.1 Cyberdyne Company Information
  3. 8.1.2 Cyberdyne Business Overview
  4. 8.1.3 Cyberdyne Exoskeleton Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cyberdyne Exoskeleton Product Portfolio
  6. 8.1.5 Cyberdyne Recent Developments
  7. 8.2 Hocoma
  8. 8.2.1 Hocoma Company Information
  9. 8.2.2 Hocoma Business Overview
  10. 8.2.3 Hocoma Exoskeleton Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hocoma Exoskeleton Product Portfolio
  12. 8.2.5 Hocoma Recent Developments
  13. 8.3 ReWalk Robotics
  14. 8.3.1 ReWalk Robotics Company Information
  15. 8.3.2 ReWalk Robotics Business Overview
  16. 8.3.3 ReWalk Robotics Exoskeleton Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ReWalk Robotics Exoskeleton Product Portfolio
  18. 8.3.5 ReWalk Robotics Recent Developments
  19. 8.4 Ekso Bionics
  20. 8.4.1 Ekso Bionics Company Information
  21. 8.4.2 Ekso Bionics Business Overview
  22. 8.4.3 Ekso Bionics Exoskeleton Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ekso Bionics Exoskeleton Product Portfolio
  24. 8.4.5 Ekso Bionics Recent Developments
  25. 8.5 LockHeed Martin
  26. 8.5.1 LockHeed Martin Company Information
  27. 8.5.2 LockHeed Martin Business Overview
  28. 8.5.3 LockHeed Martin Exoskeleton Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 LockHeed Martin Exoskeleton Product Portfolio
  30. 8.5.5 LockHeed Martin Recent Developments
  31. 8.6 Parker Hannifin
  32. 8.6.1 Parker Hannifin Company Information
  33. 8.6.2 Parker Hannifin Business Overview
  34. 8.6.3 Parker Hannifin Exoskeleton Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Parker Hannifin Exoskeleton Product Portfolio
  36. 8.6.5 Parker Hannifin Recent Developments
  37. 8.7 Interactive Motion Technologies
  38. 8.7.1 Interactive Motion Technologies Company Information
  39. 8.7.2 Interactive Motion Technologies Business Overview
  40. 8.7.3 Interactive Motion Technologies Exoskeleton Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Interactive Motion Technologies Exoskeleton Product Portfolio
  42. 8.7.5 Interactive Motion Technologies Recent Developments
  43. 8.8 Panasonic
  44. 8.8.1 Panasonic Company Information
  45. 8.8.2 Panasonic Business Overview
  46. 8.8.3 Panasonic Exoskeleton Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Panasonic Exoskeleton Product Portfolio
  48. 8.8.5 Panasonic Recent Developments
  49. 8.9 Myomo
  50. 8.9.1 Myomo Company Information
  51. 8.9.2 Myomo Business Overview
  52. 8.9.3 Myomo Exoskeleton Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Myomo Exoskeleton Product Portfolio
  54. 8.9.5 Myomo Recent Developments
  55. 8.10 B-TEMIA Inc.
  56. 8.10.1 B-TEMIA Inc. Company Information
  57. 8.10.2 B-TEMIA Inc. Business Overview
  58. 8.10.3 B-TEMIA Inc. Exoskeleton Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 B-TEMIA Inc. Exoskeleton Product Portfolio
  60. 8.10.5 B-TEMIA Inc. Recent Developments
  61. 8.11 Alter G
  62. 8.11.1 Alter G Company Information
  63. 8.11.2 Alter G Business Overview
  64. 8.11.3 Alter G Exoskeleton Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Alter G Exoskeleton Product Portfolio
  66. 8.11.5 Alter G Recent Developments
  67. 8.12 US Bionics
  68. 8.12.1 US Bionics Company Information
  69. 8.12.2 US Bionics Business Overview
  70. 8.12.3 US Bionics Exoskeleton Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 US Bionics Exoskeleton Product Portfolio
  72. 8.12.5 US Bionics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exoskeleton Value Chain Analysis
  2. 9.1.1 Exoskeleton Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exoskeleton Sales Mode & Process
  6. 9.2 Exoskeleton Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exoskeleton Distributors
  9. 9.2.3 Exoskeleton Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst